Alcoholic liver disease
Conditions
Interventions
Treatment group:Liuwei Zhiji Gegen Sangshen oral liquid
Control group:Placebo of the Liuwei Zhiji Gegen Sangshen oral liquid
Sponsors
The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients who met the western medical diagnostic criteria of ALD, mild ALD, alcoholic fatty liver and mild alcoholic hepatitis without obvious clinical discomfort were selected as study subjects. (1) Mild ALD: the liver biochemical, imaging and histopathological examinations were basically normal or slightly abnormal; (2) Alcoholic fatty liver: imaging diagnosis meets the criteria of fatty liver, and serum ALT, AST or GGT may be slightly abnormal; (3) Mild alcoholic hepatitis: elevated serum ALT, AST or GGT, and may have elevated serum TBIL; Inclusion age criteria Patients between 18-70 years old; those who signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Liver injury caused by viral infection, metabolic abnormalities, drugs and poisons; 2. Autoimmune liver disease; 3. Liver cancer; 4. Pregnant or lactating women; 5. Pregnancy preparation; 6. Severe heart, liver, kidney and hematopoietic system diseases; 7. Allergic to the drugs used in this study; 8. Redrinkers during treatment; 9. Psychiatric patients can not cooperate; 10. Can not adhere to 3 courses (3 months) of treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver Elasticity Test; | — |
Secondary
| Measure | Time frame |
|---|---|
| liver function test;Blood lipid testingBlood lipid testing;Body mass index;Liver ultrasound examination; | — |
Countries
China
Contacts
Public ContactZhi Li
The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University
Outcome results
None listed